Advertisement
Advertisement
CTNM
Contineum Therapeutics, Inc. Class A Common Stock
12.51
USDSponsored
-0.89
-6.64%
Sep 23, 16:00 UTC -4
Closed
After-Market
12.53
+0.02
+0.12%
Contineum Therapeutics, Inc. Class A Common Stock Financial Snapshot
| Market Cap | 471.20M |
| Beta | 0.75 |
| Earnings Per Share (EPS) | -1.73 |
| Price-to-Book (P/B) Ratio | 2.13 |
| Operating Margin | -- |
| Total Debt/Equity (D/E) | 0.00% |
| P/E Ratio | -- |
| Return on Equity (ROE) | -24.73% |
| Current Ratio | 37.17% |
| Free Cash Flow | -28.09M |
